EIF4H anticorps (C-Term)
Aperçu rapide pour EIF4H anticorps (C-Term) (ABIN633301)
Antigène
Voir toutes EIF4H AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- EIF4 H antibody was raised against the C terminal of EIF4
-
Purification
- Affinity purified
-
Immunogène
- EIF4 H antibody was raised using the C terminal of EIF4 corresponding to a region with amino acids TEEERAQRPRLQLKPRTVATPLNQVANPNSAIFGGARPREEVVQKEQE
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
EIF4H Blocking Peptide, (ABIN5613350), is also available for use as a blocking control in assays to test for specificity of this EIF4H antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EIF0 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- EIF4H (Eukaryotic Translation Initiation Factor 4H (EIF4H))
-
Autre désignation
- EIF4H
-
Sujet
- EIF4H is one of the translation initiation factors, which functions to stimulate the initiation of protein synthesis at the level of mRNA utilization. This gene is deleted in Williams syndrome, a multisystem developmental disorder caused by the deletion of contiguous genes at 7q11.23. Alternative splicing of this gene generates 2 transcript variants.
-
Poids moléculaire
- 27 kDa (MW of target protein)
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-